- ≥99% by HPLC per component; lot-matched COA available
- Lot-matched certificate of analysis
- Ships next business day, tracked
BPC-157 + KPV
Co-formulated repair and inflammatory-signalling blend in one lyophilized vial
- FormLyophilized powder, sealed glass vial with crimped stopper
- Research areasGastrointestinal mucosal models, inflammatory signalling, tissue repair, NF-kappa B pathway activity
Supplied for laboratory research use only. Not for human or veterinary use, and not intended to diagnose, treat, cure or prevent any disease.
Overview
This blend puts two short peptides into a single lyophilized vial at a 1:1 mass ratio: BPC-157, the fifteen-residue gastric pentadecapeptide derived from body protection compound, and KPV, the three-residue C-terminal fragment of alpha-melanocyte-stimulating hormone. The 10 mg vial contains 5 mg of each; the 20 mg vial contains 10 mg of each.
Specifications
Supply & purity
- Form
- Lyophilized powder, sealed glass vial with crimped stopper
- Purity
- ≥99% by HPLC per component; lot-matched COA available
- Available sizes
- 10 mg total (5 mg BPC-157 / 5 mg KPV); 20 mg total (10 mg / 10 mg)
- Solubility
- Both peptides dissolve readily in bacteriostatic or sterile water
Handling & storage
- Storage (lyophilized)
- −20 °C, sealed and protected from light and moisture
- Storage (reconstituted)
- 2–8 °C, protected from light, used within the study window
Additional detail
- Product type
- Co-formulated two-peptide blend, single vial
- Blend ratio
- 1:1 by mass
- BPC-157
- CAS 137525-51-0 · C62H98N16O22 · 1419.55 g/mol
- BPC-157 sequence
- Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
- KPV
- CAS 67727-97-3 · C16H30N4O4 · 342.43 g/mol
- KPV sequence
- Lys-Pro-Val (alpha-MSH 11–13 C-terminal fragment)
- Research areas
- Gastrointestinal mucosal models, inflammatory signalling, tissue repair, NF-kappa B pathway activity
Questions about BPC-157 + KPV
What is in the BPC-157 + KPV vial?
One lyophilized vial containing both peptides at a 1:1 mass ratio. The 10 mg option holds 5 mg of BPC-157 and 5 mg of KPV; the 20 mg option holds 10 mg of each. There is no diluent, carrier or preservative in the vial — only the two peptides.
How does the blend differ from buying the peptides separately?
A blend fixes the ratio at manufacture and needs one reconstitution, which simplifies preparation and reduces vial-to-vial handling. Separate vials let a researcher set any ratio and run single-peptide control arms. Studies designed to attribute an effect to one component usually need the separate vials as well.
Is a certificate of analysis available?
Yes. Each component is assayed by HPLC to a ≥99% purity specification with mass-spectrometric identity confirmation, and the finished blend lot carries a matched certificate of analysis covering both peptides. Current lot COAs can be requested before ordering.
What solvent is used to reconstitute it?
Both peptides are freely water-soluble, so bacteriostatic water is the usual choice for multi-draw preparations and sterile water for single-use ones. Add the diluent slowly against the vial wall and swirl rather than shake; the solution should be clear and colourless with no visible particulates.
How long does the reconstituted blend last?
Kept at 2–8 °C, protected from light and drawn with aseptic technique, reconstituted short peptides are typically used within a few weeks in laboratory practice. Define the study window in the protocol, avoid repeated warming, and discard any preparation that becomes cloudy or shows particulates.
Related
